Pharmaceutical preparations; pharmaceutical preparations for the treatment of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders; pharmaceutical preparations for the prevention and treatment of Parkinson's disease, Alzheimer's, ALS, huntington's, and diseases of aging; therapeutic agents for removal of damaged mitochondrial cells for medical purposes; medical diagnostic tests, biomarkers and assays for detection of Parkinson's disease, Alzheimer's, ALS, Huntington's, diseases of aging, and other mitochondrial diseases.;
Pharmaceutical research and development services in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's disease, Alzheimer's, ALS, Huntington's, and diseases of aging; providing medical and scientific research and information in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's disease, Alzheimer's, ALS, Huntington's, and diseases of aging; diagnostic research and development services for drug discovery in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's, Alzheimer's, ALS, Huntington's, and diseases of aging.;